🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with attain-2: orforglipron in t2dm? Page 5

Has anyone dealt with attain-2: orforglipron in t2dm?

LipidDoc_ATL Thu, Feb 19, 2026 at 5:55 AM 25 replies 1,000 viewsPage 5 of 5
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Feb 26, 2026 at 12:11 AM#21
jason_paloalto said:
One habit that pays for itself: post the method alongside the number.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

50 0hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 47 others
Reply Quote Save Share Report
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Feb 27, 2026 at 2:56 PM#22
jason_paloalto said:
One habit that pays for itself: post the method alongside the number.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

49 24AttorneyGrant, DebRD_ATL, KristenIndy and 46 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Mar 1, 2026 at 5:42 AM#23
jason_paloalto said:
One habit that pays for itself: post the method alongside the number.

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

48 23cory_ATX, lori_vegas, Dr.PulmRoch and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Mar 2, 2026 at 8:29 PM#24

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

47 22ricardo_MIA, BrianDallas92, labquiet_amy and 44 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Mar 4, 2026 at 11:17 AM#25
PeptideChemSF said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Second this.

Last edited: Mar 4, 2026 at 2:17 PM
46 21labquiet_amy, emily_PDX, Dr.SleepRoch and 43 others
Reply Quote Save Share Report
1345

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register